Guardion Health Sciences, Inc. Common Stock
GHSI
GHSI was delisted on the 11th of October, 2024.
15 hedge funds and large institutions have $944K invested in Guardion Health Sciences, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
9% more capital invested
Capital invested by funds: $867K → $944K (+$77K)
17% less funds holding
Funds holding: 18 → 15 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$744K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$106K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$87.5K |
| 4 |
Renaissance Technologies
New York
|
+$42.5K |
| 5 |
VF
Virtu Financial
New York
|
+$37.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$81K |
| 2 |
Jane Street
New York
|
-$40K |
| 3 |
Squarepoint
New York
|
-$6K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.28K |
GHSI Hedge Fund Activity: Q3 2020 in Review
15 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Guardion Health Sciences, Inc. Common Stock (GHSI) for Q3 2020, worth a combined $944K — up 8.9% from $867K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of GHSI and 2 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 7 added.
The largest buyer was Vanguard Group, adding an estimated $744K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $81K sold.
- 15 institutional investors held Guardion Health Sciences, Inc. Common Stock (GHSI) as of Q3 2020, down from 18 in Q2 2020.
- Funds reported $944K of Guardion Health Sciences, Inc. Common Stock stock for Q3 2020, up 8.9% quarter-over-quarter.
- 2 funds opened new Guardion Health Sciences, Inc. Common Stock positions in Q3 2020 and 5 closed out, a net change of -3 holders.
- The largest Guardion Health Sciences, Inc. Common Stock buyer in Q3 2020 was Vanguard Group, an estimated $744K added.
- The largest Guardion Health Sciences, Inc. Common Stock seller in Q3 2020 was Susquehanna International Group, an estimated $81K sold.
Based on aggregated 13F filings for Q3 2020.